Appendix 4C – Q2 FY25 Quarterly Cash Flow Report
Highlights Topline data for ATH434-201 randomized, double-blind Phase 2 clinical trial on track for expected release by early February 2025ATH434-201 trial in early-stage MSA completed in November ...
Paper Explores Utility of Biomarker Testing in Early Diagnosis and Treatment of ...
New biomarker tests can enable early diagnosis and prompt treatment of symptoms associated with synucleinopathies, according ...